(Q28181343)

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

author name string

Daniel J Goldstein

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

Robert B Beauford

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

language of work or name

English

0 references

publication date

June 2003

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

The Annals of Thoracic Surgery

25 May 2017

published in

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

volume

75

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

issue

6 Suppl

0 references

6

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

25 May 2017

page(s)

S42-7

0 references

S42-S47

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8

Preventing, minimizing, and managing postoperative bleeding

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Control of perigraft bleeding during ventricular assist device implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Blood transfusion: the silent epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

The active principle in feverfew

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Antiplatelet components in Panax ginseng

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Vitamin K reduces bleeding in left ventricular assist device recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Hemorrhage associated with vitamin C deficiency in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

The fibrinolytic system in human ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Coagulation disturbances following ascites recirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Utility of whole blood hemostatometry using the clot signature analyzer for assessment of hemostasis in cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Anaphylaxis associated with white-cell reduction filter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900478-8

10.1016/S0003-4975(03)00478-8

7 January 2021

Identifiers

DOI

1 reference

https://doi.org/10.1016%2FS0003-4975%2803%2900478-8